Core Cap Advisors, LLC Pro Phase Labs, Inc. Transaction History
Core Cap Advisors, LLC
- $2.18 Billion
- Q1 2025
A detailed history of Core Cap Advisors, LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 3,500 shares of PRPH stock, worth $1,225. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,500
Previous 100
3400.0%
Holding current value
$1,225
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PRPH
# of Institutions
37Shares Held
4.95MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT1.53MShares$533,9630.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$142,8930.0% of portfolio
-
Four World Capital Management LLC New York, NY377KShares$131,8010.1% of portfolio
-
Quinn Opportunity Partners LLC Charlottesville, VA318KShares$111,3440.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny300KShares$104,9330.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $5.61M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...